Lepu Biopharma Co., Ltd. (LEPU BIO) filed its monthly return on movements in securities for the period ended 31 July 2026, indicating that the company’s share structure remained unchanged during the month.

Authorised and Issued Capital • Authorised/registered share capital stood at 1.80 billion shares with a par value of RMB 1 each, representing RMB 1.80 billion. • Issued share capital likewise totalled 1.80 billion shares, unchanged from the previous month. • No treasury shares were held, issued, or cancelled during the period.

Public Float Status • The company confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent of issued H-shares.

Corporate Actions • No movements were recorded under share options, warrants, convertible securities, or other equity-linked instruments. • No buy-backs, cancellations, or other alterations to share capital occurred.

Regulatory Confirmation • The submission, signed by Joint Company Secretary Ms. Li Yunyi on 3 August 2026, affirms that all statutory and listing-rule obligations related to any prior securities issues or transfers have been fulfilled.

With share capital stable and regulatory compliance affirmed, LEPU BIO’s equity structure enters August 2026 unchanged.